farnesol has been researched along with Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barreto, AS; Batista, MVA; Carvalho, JS; de Souza Araújo, AA; Dos Santos, DM; Oliveira Santos, LAB; Oliveira, AMS; Quintans-Júnior, LJ; Serafini, MR; Silva, EAP; Siqueira Quintans, JS; Viana Santos, MR | 1 |
| Bychkov, R; Gollasch, M; Gross, V; Haller, H; Hofmann, F; Luft, FC; Luft, UC; McCarron, DA; Ried, C; Roullet, JB; Yagil, C; Yagil, Y | 1 |
| Knapp, DR; Langman, MJ; Wakley, EJ | 1 |
1 trial(s) available for farnesol and Hypertension
| Article | Year |
|---|---|
Treatment of chronic gastric ulcer with carbenoxolone and gefarnate: a comparative trial.
Topics: Body Weight; Chronic Disease; Clinical Trials as Topic; Diuretics; Edema; Farnesol; Fatty Acids; Female; Glycyrrhiza; Humans; Hypertension; Male; Plants, Medicinal; Potassium; Sodium; Stomach Ulcer; Terpenes | 1973 |
2 other study(ies) available for farnesol and Hypertension
| Article | Year |
|---|---|
Cardiovascular effects of farnesol and its β-cyclodextrin complex in normotensive and hypertensive rats.
Topics: Animals; Arterial Pressure; beta-Cyclodextrins; Blood Pressure; Bradycardia; Cardiovascular Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesol; Heart Rate; Hypertension; Male; Molecular Docking Simulation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar | 2021 |
Farnesol blocks the L-type Ca2+ channel by targeting the alpha 1C subunit.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; CHO Cells; Cricetinae; Farnesol; GTP-Binding Proteins; Hypertension; Male; Membrane Potentials; Muscle, Smooth, Vascular; Rats | 1999 |